Farmacja

AbbVie stock (ABBV): FDA clears new Venclexta-Calquence CLL combo — what to watch Monday
···

Akcje AbbVie (ABBV): FDA zatwierdza nową kombinację Venclexta-Calquence w leczeniu CLL — na co zwrócić uwagę w poniedziałek

Amerykańska FDA zatwierdziła nową terapię pierwszego rzutu dla przewlekłej białaczki limfocytowej, łącząc Calquence AstraZeneca z Venclexta AbbVie. Akcje AbbVie wzrosły w piątek o 0,21% do 224,81 USD. Nowy schemat poprawił przeżycie wolne od progresji w badaniu AMPLIFY. Barclays wyznaczył cenę docelową akcji AbbVie na 275 USD.
23 lutego, 2026

Stock Market Today

  • Rising Costs of Essentials: Why Eggs, Bread and Milk Are More Expensive
    May 23, 2026, 11:58 PM EDT. Everyday essentials like eggs, milk, and bread have seen significant price hikes in recent years. Eggs, once £1 for six, now cost £1.80 due to avian flu outbreaks that decimated hen populations and increased energy costs for producers. Milk prices rose from £1.29 to £1.65 for four pints, driven by higher energy expenses in dairy farming and processing amid geopolitical tensions. Grain price spikes linked to the Russia-Ukraine conflict further strained costs. Despite these increases, farmers face shrinking margins with dairy farmers paid 25% less per litre. Producer input costs rose 7.7% year-on-year, outpacing the 4% rise in factory gate prices, squeezing the supply chain. Demand remains strong, particularly for high-protein foods, keeping prices elevated.